The aim of this data collection is to investigate the influence of durvalumab maintenance therapy on treatment success in patients
with small cell lung cancer after definitive chemoradiotherapy. In particular, the aim is to
analyze how the response after definitive chemoradiotherapy was over time without durvalumab as
maintenance therapy alone compared to the combination, and which factors (e.g., age, tolerability) influence the
course of therapy. The study will combine both prospective and retrospective data collection in order to obtain a comprehensive picture of current treatment practice and a historical perspective on the development of therapeutic approaches. This
will enable an informed assessment of the most effective treatment strategies for small cell lung cancer and
could provide important insights for future therapeutic decisions.
The aim of this data collection is to investigate the influence of durvalumab maintenance therapy on treatment success in patients
with small cell lung cancer after definitive chemoradiotherapy. In particular, the aim is to
analyze how the response after definitive chemoradiotherapy was over time without durvalumab as
maintenance therapy alone compared to the combination, and which factors (e.g., age, tolerability) influence the
course of therapy. The study will combine both prospective and retrospective data collection in order to obtain a comprehensive picture of current treatment practice and a historical perspective on the development of therapeutic approaches. This
will enable an informed assessment of the most effective treatment strategies for small cell lung cancer and
could provide important insights for future therapeutic decisions.
